Brief: Aethlon Receives Clearance From Drug Controller General Of India For Potential Phase 1 Trial Of Its Hemopurifier® In Oncology
Oct 10 (Reuters) - Aethlon Medical Inc AEMD.O :
* AETHLON RECEIVES CLEARANCE FROM DRUG CONTROLLER GENERAL OF
INDIA
FOR POTENTIAL PHASE 1 TRIAL OF ITS HEMOPURIFIER® IN ONCOLOGY
* AETHLON:SEES TRIAL TO BEGIN POST INTERNAL IN VITRO BINDING
STUDY
OF RELEVANT TARGETS, APPROVAL BY RESPECTIVE ETHICS BOARDS OF
INTERESTED SITES IN INDIA
Source text for Eikon: ID:nPn2rR63Da
Further company coverage: AEMD.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Aethlon Medical
See all newsU.S. STOCKS ON THE MOVE -Nebius, Securitize, Viant Technology
U.S. STOCKS ON THE MOVE -GlobalFoundries, Lucid, Phillips 66
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Applied Digital
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Aethlon Medical
Aethlon Medical skyrockets after merger with North Immunology